The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 131-136 , July 2007

Regional differences in EpiPen prescriptions in the United States: The potential role of vitamin D

  • Carlos A. Camargo Jr., MD, DrPH

      Affiliations

    • From the Center for D-receptor Activation Research
    • Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston
    • Corresponding Author InformationReprint requests: Carlos A. Camargo, Jr, MD, DrPH, EMNet Coordinating Center, Massachusetts General Hospital, 326 Cambridge Street, Suite 410, Boston, MA 02114.
    • ,
  • Sunday Clark, MPH, ScD

      Affiliations

    • Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston
    • ,
  • Michael S. Kaplan, MD

      Affiliations

    • Department of Allergy, Kaiser Permanente, Los Angeles
    • ,
  • Philip Lieberman, MD

      Affiliations

    • University of Tennessee College of Medicine, Memphis
    • ,
  • Robert A. Wood, MD

      Affiliations

    • Division of Pediatric Allergy and Immunology, Department of Pediatrics, Johns Hopkins Medical Center, Baltimore

Received 5 September 2006 ,Revised 26 March 2007 ,Accepted 26 March 2007.

References 

  1. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med. 2001;161:15–21
  2. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol. 1999;104:452–456
  3. Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol. 2004;113:536–542
  4. Simons FE, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol. 2002;110:647–651
  5. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Int Med. 2004;164:317–319
  6. Gupta R, Sheikh A, Strachan DP, Anderson HR. Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy. 2004;34:520–526
  7. Lieberman P, Camargo CA, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology (ACAAI) Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006;97:596–602
  8. Camargo CA, Rifas-Shiman SL, Litonjua AA, Rich-Edwards JW, Weiss ST, Gold DR, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am J Clin Nutr. 2007;85:788–795
  9. US Census Bureau web site. Available at: http://www.census.gov/population/www/index.html. Accessed August 1, 2006.
  10. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) web site. Available at: http://www.cdc.gov/asthma/brfss/default.htm. Accessed June 1, 2006.
  11. National Oceanic and Atmospheric Adminstration (NOAA) web site. Available at: http://www.noaa.gov/. Accessed June 1, 2006.
  12. Ivry GB, Ogle CA, Shim EK. Role of sun exposure in melanoma. Dermatol Surg. 2006;32:481–492
  13. Oliveria SA, Saraiya M, Geller AC, Heneghan MK, Jorgensen C. Sun exposure and risk of melanoma. Arch Dis Child. 2006;91:131–138
  14. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29
  15. Hernan MA, Olek MJ, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology. 1999;53:1711–1718
  16. Brown SJ. The role of vitamin D in multiple sclerosis. Ann Pharmacother. 2006;40:1158–1161
  17. Feldman D, Pike JW, Glorieux FH. Vitamin D. 2nd ed.. Amsterdam: Elsevier Academic Press; 2005;
  18. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373–378
  19. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–783
  20. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317–322
  21. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117–145
  22. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays. 2004;26:21–28
  23. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51:1367–1374
  24. Meehan MA, Kerman RH, Lemire JM. 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol. 1992;140:400–409
  25. Schwartz RH. Natural regulatory T cells and self-tolerance. Nat Immunol. 2005;6:327–330
  26. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(suppl 6):1717S–1720S
  27. Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, Willheim M. 1 Alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res. 2002;52:12–18
  28. Annesi-Maesano I. Perinatal events, vitamin D, and the development of allergy. Pediatr Res. 2002;52:3–5
  29. Simons FE. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol. 2006;117:367–377

 The NDCHealth prescription data were purchased by Dey (Napa, Calif).Disclosure of potential conflict of interest: C. A. Camargo, Jr, has consulting arrangements with Dey and has received grant support from Dey and Verus. M. S. Kaplan has consulting arrangements with Dey and the EpiPen Advisory Committee and has received grant support from Genentech and the Childhood Asthma Research and Education Network. P. Lieberman has consulting arrangements with Dey and Verus; is on the speakers' bureau for Dey, Verus, Sanofi-Aventis, Genentech, Medpointe, and GlaxoSmithKline; and has served as an expert witness for Medpointe. R. A. Wood has consulting arrangements with Dey and has received grant support from Merck and Genentech. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(07)00755-5

doi: 10.1016/j.jaci.2007.03.049

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 1 , Pages 131-136 , July 2007

Article Tools

* Image Usage & Resolution